Current Environment: Production

Boston
617-730-0569
617-355-6129
Massachusetts
02115
300 Longwood Avenue

Division of Nephrology | Education

Undergraduate School

St. Lawrence University

1992, Canton, NY

Medical School

University of Vermont College of Medicine

2001, Burlington, VT

Internship

Pediatrics

University of Vermont/Fletcher Allen Health Care

2002, Burlington, VT

Residency

Pediatrics

University of Vermont/Fletcher Allen Health Care

2004, Burlington, VT

Residency

Chief Resident in Pediatrics

University of Vermont/Fletcher Allen Health Care

2005, Burlington, VT

Fellowship

Pediatric Nephrology

Boston Children's Hospital

2008, Boston, MA

Division of Nephrology | Publications

  1. Lesion network mapping predicts post-stroke behavioural deficits and improves localization. Brain. 2021 05 07; 144(4):e35. View Lesion network mapping predicts post-stroke behavioural deficits and improves localization. Abstract

  2. Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Am J Hum Genet. 2020 10 01; 107(4):727-742. View Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Abstract

  3. Correction to: Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Pediatr Radiol. 2020 May; 50(5):755-756. View Correction to: Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Abstract

  4. Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Pediatr Radiol. 2020 05; 50(5):698-705. View Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Abstract

  5. Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy. Pediatr Crit Care Med. 2019 11; 20(11):1069-1077. View Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy. Abstract

  6. Renal replacement therapy in the pediatric cardiac intensive care unit. J Thorac Cardiovasc Surg. 2019 11; 158(5):1446-1455. View Renal replacement therapy in the pediatric cardiac intensive care unit. Abstract

  7. Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. J Am Soc Nephrol. 2018 09; 29(9):2348-2361. View Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. Abstract

  8. Should ACE inhibitors and ARBs be used in combination in children? Pediatr Nephrol. 2019 09; 34(9):1521-1532. View Should ACE inhibitors and ARBs be used in combination in children? Abstract

  9. African trypanosomes evade immune clearance by O-glycosylation of the VSG surface coat. Nat Microbiol. 2018 08; 3(8):932-938. View African trypanosomes evade immune clearance by O-glycosylation of the VSG surface coat. Abstract

  10. Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. Ann Surg. 2018 06; 267(6):e109-e111. View Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. Abstract

  11. Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Hypertension. 2018 04; 71(4):691-699. View Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Abstract

  12. Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children. J Vasc Surg. 2018 06; 67(6):1664-1672. View Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children. Abstract

  13. The authors reply. Pediatr Crit Care Med. 2017 12; 18(12):1191. View The authors reply. Abstract

  14. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 01 06; 13(1):53-62. View Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Abstract

  15. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018 01; 93(1):204-213. View Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Abstract

  16. Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Pediatr Nephrol. 2018 02; 33(2):305-314. View Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Abstract

  17. Catheter-Directed Thrombolysis in a Child with Bilateral Renal Artery Graft Thrombosis. J Vasc Interv Radiol. 2017 Aug; 28(8):1184-1188. View Catheter-Directed Thrombolysis in a Child with Bilateral Renal Artery Graft Thrombosis. Abstract

  18. Acute Kidney Injury After Pediatric Cardiac Surgery: A Secondary Analysis of the Safe Pediatric Euglycemia After Cardiac Surgery Trial. Pediatr Crit Care Med. 2017 Jul; 18(7):638-646. View Acute Kidney Injury After Pediatric Cardiac Surgery: A Secondary Analysis of the Safe Pediatric Euglycemia After Cardiac Surgery Trial. Abstract

  19. The effect of an electronic health record-based tool on abnormal pediatric blood pressure recognition. Congenit Heart Dis. 2017 Jul; 12(4):484-490. View The effect of an electronic health record-based tool on abnormal pediatric blood pressure recognition. Abstract

  20. In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals. Congenit Heart Dis. 2016 Jul; 11(4):309-14. View In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals. Abstract

  21. Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet. 2016 06 02; 98(6):1228-1234. View Mutations in SLC26A1 Cause Nephrolithiasis. Abstract

  22. Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. J Bioenerg Biomembr. 2016 06; 48(3):269-79. View Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. Abstract

  23. Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control. 2016; 9:49-58. View Evaluation and treatment of hypertensive crises in children. Abstract

  24. Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):664-72. View Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. Abstract

  25. In vitro generation of human pluripotent stem cell derived lung organoids. Elife. 2015 Mar 24; 4. View In vitro generation of human pluripotent stem cell derived lung organoids. Abstract

  26. Commentary on "protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion". South Med J. 2015 Jan; 108(1):49-50. View Commentary on "protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion". Abstract

  27. Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Dec; 8(12):e3373. View Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis. Abstract

  28. Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis. J Med Chem. 2014 Dec 11; 57(23):9855-69. View Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis. Abstract

  29. Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2014 Oct; 29(10):1839-47. View Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. Abstract

  30. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale. Am J Cardiol. 2014 Nov 15; 114(10):1584-9. View Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale. Abstract

  31. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J. 2014 Aug; 41(4):357-67. View Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Abstract

  32. Identification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Jul; 8(7):e2976. View Identification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasis. Abstract

  33. Proteomic selection of immunodiagnostic antigens for Trypanosoma congolense. PLoS Negl Trop Dis. 2014 Jun; 8(6):e2936. View Proteomic selection of immunodiagnostic antigens for Trypanosoma congolense. Abstract

  34. Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals. J Am Soc Hypertens. 2014 Sep; 8(9):660-7. View Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals. Abstract

  35. Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Pediatr Nephrol. 2013 Oct; 28(10):2023-33. View Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Abstract

  36. Rational use of antihypertensive medications in children. Pediatr Nephrol. 2014 Jun; 29(6):979-88. View Rational use of antihypertensive medications in children. Abstract

  37. High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis. Pediatr Pulmonol. 2014 Feb; 49(2):148-53. View High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis. Abstract

  38. Aorto-mesenteric and renal allograft transplant: a novel treatment for midaortic syndrome. Am J Transplant. 2013 Apr; 13(4):1088-1092. View Aorto-mesenteric and renal allograft transplant: a novel treatment for midaortic syndrome. Abstract

  39. A novel treatment for the midaortic syndrome. N Engl J Med. 2012 Dec 13; 367(24):2361-2. View A novel treatment for the midaortic syndrome. Abstract

  40. Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2013 Jul; 146(1):146-52. View Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. Abstract

  41. Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet. Am J Hematol. 2012 Aug; 87(8):816-8. View Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet. Abstract

  42. Established and emerging markers of kidney function. Clin Chem. 2012 Apr; 58(4):680-9. View Established and emerging markers of kidney function. Abstract

  43. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010 Apr; 77(8):708-14. View Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Abstract

  44. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 Dec; 1(3):200-8. View Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Abstract

  45. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008 Mar 20; 245(3):182-93. View Biomarkers of nephrotoxic acute kidney injury. Abstract

  46. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008; 48:463-93. View Biomarkers of acute kidney injury. Abstract

  47. Comparison of Fy(b) status as determined serologically and genetically. Transfus Med. 1997 Jun; 7(2):135-41. View Comparison of Fy(b) status as determined serologically and genetically. Abstract

Division of Nephrology | Education

Medical School

MBBS

Government Medical College

2010, Surat, India

Residency

Albert Einstein Medical Center

2015, Philadelphia, PA

Fellowship

Boston Children's Hospital

2018, Boston, MA

Division of Nephrology | Publications

Division of Nephrology | Education

Undergraduate School

Northwestern University

1987, Evanston, IL

Medical School

Northwestern University Medical School

1989, Chicago, IL

Internship

Pediatrics

Children's Memorial Hospital

1990, Chicago, IL

Residency

Pediatrics

Children's Memorial Hospital

1992, Chicago, IL

Fellowship

Pediatric Nephrology

Boston Children's Hospital

1996, Boston, MA

Division of Nephrology | Publications

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services
BESbswy